Physician profile
Summer M Monroe
NPI 1396018404
$3,082.11
in general payments reported to CMS, 2019-2025
22 companies · $796 in 2025
The $796 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $518 · 2022: $694 · 2023: $373 · 2024: $701 · 2025: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748 · Education: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.50 |
| Education | $122.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,022.42 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $535.38 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $279.24 | 2024-2025 | Dupixent |
| Pfizer INC. | $204.85 | 2021-2024 | |
| Amgen INC. | $136.01 | 2021-2025 | Tezspire, Repatha, Otezla |
| Abbvie INC. | $124.02 | 2021-2022 | |
| Grifols USA, LLC | $117.28 | 2025 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $99.80 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.48 | 2021-2022 | |
| Astellas Pharma US INC | $84.37 | 2023 | Veozah |
| Optinose US, INC. | $64.92 | 2024-2025 | |
| Boston Scientific Corporation | $64.37 | 2025 | Watchman Flx |
| Esperion Therapeutics, INC. | $46.81 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.84 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $39.44 | 2023-2024 | Farxiga, Breztri |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $24.47 | 2021 | |
| Biogen, INC. | $22.73 | 2021 | |
| Stryker Corporation | $19.62 | 2025 | Audion Et Dilation System |
| Biohaven Pharmaceuticals, INC. | $19.58 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.29 | 2022 | |
| Lilly USA, LLC | $16.85 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Summer Monroe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.